359 related articles for article (PubMed ID: 36917241)
1. The role of the ATP-adenosine axis in ischemic stroke.
Schädlich IS; Winzer R; Stabernack J; Tolosa E; Magnus T; Rissiek B
Semin Immunopathol; 2023 May; 45(3):347-365. PubMed ID: 36917241
[TBL] [Abstract][Full Text] [Related]
2. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
3. [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review].
Wang C; Yin Q; Su Z; Xia L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1134-1140. PubMed ID: 33325366
[TBL] [Abstract][Full Text] [Related]
4. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signaling: a potential therapeutic target for ischemic stroke.
Wang L; Li YJ; Yang X; Yang B; Zhang X; Zhang J; Zhang Q; Cheng XD; Wang JH; Yu NW
Purinergic Signal; 2023 Mar; 19(1):173-183. PubMed ID: 36370253
[TBL] [Abstract][Full Text] [Related]
6. Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes.
Pasquini S; Vincenzi F; Casetta I; Laudisi M; Merighi S; Gessi S; Borea PA; Varani K
Cells; 2020 Apr; 9(5):. PubMed ID: 32344922
[TBL] [Abstract][Full Text] [Related]
7. Purine Release, Metabolism, and Signaling in the Inflammatory Response.
Linden J; Koch-Nolte F; Dahl G
Annu Rev Immunol; 2019 Apr; 37():325-347. PubMed ID: 30676821
[TBL] [Abstract][Full Text] [Related]
8. The role of the CD39-CD73-adenosine pathway in liver disease.
Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
[TBL] [Abstract][Full Text] [Related]
9. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts.
Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H
Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770
[TBL] [Abstract][Full Text] [Related]
10. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
Silva-Vilches C; Ring S; Mahnke K
Front Immunol; 2018; 9():2581. PubMed ID: 30473700
[TBL] [Abstract][Full Text] [Related]
11. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP and adenosine: The Yin and Yang in immune responses?
Faas MM; Sáez T; de Vos P
Mol Aspects Med; 2017 Jun; 55():9-19. PubMed ID: 28093236
[TBL] [Abstract][Full Text] [Related]
13. Role of Purinergic Signalling in Endothelial Dysfunction and Thrombo-Inflammation in Ischaemic Stroke and Cerebral Small Vessel Disease.
Lee NT; Ong LK; Gyawali P; Nassir CMNCM; Mustapha M; Nandurkar HH; Sashindranath M
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356618
[TBL] [Abstract][Full Text] [Related]
14. Complementary Role of P2 and Adenosine Receptors in ATP Induced-Anti-Apoptotic Effects Against Hypoxic Injury of HUVECs.
Feliu C; Peyret H; Poitevin G; Cazaubon Y; Oszust F; Nguyen P; Millart H; Djerada Z
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909368
[TBL] [Abstract][Full Text] [Related]
15. Extracellular ATP signaling and clinical relevance.
Dou L; Chen YF; Cowan PJ; Chen XP
Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
[TBL] [Abstract][Full Text] [Related]
16. Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner.
Cui M; Ding H; Chen F; Zhao Y; Yang Q; Dong Q
Mol Neurobiol; 2016 Jan; 53(1):240-253. PubMed ID: 25428621
[TBL] [Abstract][Full Text] [Related]
17. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
18. Purinergic signaling in liver disease.
Vaughn BP; Robson SC; Longhi MS
Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
[TBL] [Abstract][Full Text] [Related]
19. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
Yoshida K; Ito M; Matsuoka I
Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury.
Zhai X; Chen K; Yang H; Li B; Zhou T; Wang H; Zhou H; Chen S; Zhou X; Wei X; Bai Y; Li M
J Nanobiotechnology; 2021 Sep; 19(1):274. PubMed ID: 34496892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]